Anti-vinculin antibodies as a novel biomarker in Egyptian patients with systemic sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1434-9949
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-vinculin antibodies as a novel biomarker in Egyptian patients with systemic sclerosis ; day:25 ; month:7 ; year:2022 ; pages:1-9
Clinical rheumatology ; (25.7.2022), 1-9
- Urheber
-
Ibrahim, Noha Hosni
Fawzy, Iman Mahmoud
Gouda, Tahany Mahmoud
El Sayed, Rasha Abdel Hameed
Morsi, Maha Hosni
Sabry, Al Shimaa Mohamed
Hashaad, Nashwa Ismail
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10067-022-06301-0
- URN
-
urn:nbn:de:101:1-2022100620103713348478
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ibrahim, Noha Hosni
- Fawzy, Iman Mahmoud
- Gouda, Tahany Mahmoud
- El Sayed, Rasha Abdel Hameed
- Morsi, Maha Hosni
- Sabry, Al Shimaa Mohamed
- Hashaad, Nashwa Ismail
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-carbamylated protein antibodies in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Ultrasound abnormalities of the major salivary glands in Egyptian patients with systemic sclerosis
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients
Egyptian evidence-based consensus on clinical practice recommendations for the management of systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Analysis of hsa_circ_0136256 as a biomarker for fibrosis in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Metabolomics in systemic sclerosis
Anti-carbamylated protein antibodies in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Ultrasound abnormalities of the major salivary glands in Egyptian patients with systemic sclerosis
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients
Egyptian evidence-based consensus on clinical practice recommendations for the management of systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Analysis of hsa_circ_0136256 as a biomarker for fibrosis in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Metabolomics in systemic sclerosis
Anti-carbamylated protein antibodies in systemic sclerosis
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Ultrasound abnormalities of the major salivary glands in Egyptian patients with systemic sclerosis
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients
Egyptian evidence-based consensus on clinical practice recommendations for the management of systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Analysis of hsa_circ_0136256 as a biomarker for fibrosis in systemic sclerosis
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis